A Mass Balance Study With a Microtracer Dose of 14C-esketamine in Healthy Male Participants
Clinical trial NCT02674295 · COMPLETED
Trial details
- NCT number
- NCT02674295
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-08-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.